• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Esperion Therapeutics, Inc. (ESPR)

    -NasdaqGM
    62.45 Down 3.87(5.84%) Feb 27, 4:00PM EST
    |After Hours : 62.44 Down 0.01 (0.01%) Feb 27, 4:38PM EST
    Add to Portfolio
    Prev Close:66.32
    Open:66.18
    Bid:59.00 x 100
    Ask:N/A
    1y Target Est:77.83
    Beta:2.340
    Earnings Date:Mar 3 - Mar 9 (Est.)
    Day's Range:62.41 - 66.42
    52wk Range:12.75 - 70.87
    Volume:348,970
    Avg Vol (3m):349,810
    Market Cap:964.42M
    P/E (ttm):N/A
    EPS (ttm):-2.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ESPRDown 5.84%964.42M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-2.29
    Quarterly EPS Est (Dec-14) :-0.55
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):9.34

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Esperion Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of oral, low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholestero... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback